Blockbuster Enhertu may get tumor agnostic label, targeting any HER2-expressing cancer: GlobalData
GlobalData’s consensus forecast projects global sales for Enhertu to reach $9.9 billion by 2028
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.